Compare Axon Enterprise Inc (AXON) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axon Enterprise Inc vs Novartis AG — how do they compare? Axon Enterprise Inc trades at $631 (market cap $51.69B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 5.7× Axon Enterprise Inc's market cap, and Novartis AG pays a 3.07% dividend while Axon Enterprise Inc pays none. Which is the better fit depends on your goals.
| AXON | NVS | |
|---|---|---|
Market Cap | $51.69B | $295.37B |
Sector | Technology | Health |
52-Week High | $791.62 | $168.62 |
52-Week Low | $345.94 | $119.31 |
Enterprise Value | $52.83B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axon Enterprise Inc
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
